Taking into account these facts, the aim of the current study was to analyze the in vitro effect of IL-33 on the quantitative properties of regulatory CD4+CD25highFOXP3+ T cell population in patients with type 1 diabetes. This evidence concerns the gene CD4 and type 1 diabetes mellitus.